POLICY FOR THE MANAGEMENT OF PATIENTS WITH OR SUSPECTED OF HAVING CREUTZFELDT JAKOB DISEASE (CJD) Version 4 Name of responsible (ratifying) committee Infection Prevention Management Committee Date ratified 17 March 2017 Consultant Infection Prevention & Control, Document Manager (job title) Decontamination Manager Date issued 30 March 2017 Review date 29 March 2020 Electronic location Infection Control Policies Decontamination of reusable medical devices, Related Procedural Documents Infection Control, Standard Precautions Transmissible spongiform encephalopathies (TSE’s), Creutzfeldt-Jakob Disease (CJD), variant CJD Key Words (to aid with searching) (vCJD), Safe Working and Prevention of Infection, Distribution of infectivity in tissues, principles of decontamination and quarantining of medical devices. Version Tracking Version Date Ratified Brief Summary of Changes Author 4 17/03/2017 Updated to PHE guidance IPT/HSDU 3 28/01/2015 Amended following updates to guidance D. Carter / C. Mitchell CONTENTS
POLICY FOR THE MANAGEMENT OF PATIENTS WITH OR SUSPECTED OF HAVING CREUTZFELDT JAKOB DISEASE (CJD) Version 4 Name of responsible (ratifying) committee Infection Prevention Management Committee Date ratified 17 March 2017 Document Manager (job title) Consultant Infection Prevention & Control, Decontamination Manager Date issued 30 March 2017 Review date 29 March 2020 Electronic location Infection Control Policies Related Procedural Documents Decontamination of reusable medical devices, Infection Control, Standard Precautions Key Words (to aid with searching) Transmissible spongiform encephalopathies (TSE’s), Creutzfeldt-Jakob Disease (CJD), variant CJD (vCJD), Safe Working and Prevention of Infection, Distribution of infectivity in tissues, principles of decontamination and quarantining of medical devices. Version Tracking Version Date Ratified Brief Summary of Changes Author 4 17/03/2017 Updated to PHE guidance IPT/HSDU 3 28/01/2015 Amended following updates to guidance D. Carter / C. Mitchell CONTENTS
Creutzfeldt%20Jakob%20Disease%20CJD%20Policy%20-%20Management%20of%20patients.docx